Scholarlink

<p>Glycated albumin (GA) is emerging as an alternative marker to glycated haemoglobin (HbA1c) for monitoring glycemic control, proving particularly useful in clinical settings where HbA1c loses reliability, such as in haemoglobinopathies, diabetic nephropathy, and during pregnancy. This review explores the established clinical applications and future perspectives of GA, providing insights for its potential integration into endocrinology practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Albumina glicata: nuovo parametro di controllo glicemico nella pratica endocrinologica

  • 期刊论文

  • 发表日期：

    2026年3月9日

查看全文
  • Gianluca Marzi,
  • Martina Verrienti,
  • Maria Chiara Zatelli,
  • Maria Rosaria Ambrosio

摘要

Glycated albumin (GA) is emerging as an alternative marker to glycated haemoglobin (HbA1c) for monitoring glycemic control, proving particularly useful in clinical settings where HbA1c loses reliability, such as in haemoglobinopathies, diabetic nephropathy, and during pregnancy. This review explores the established clinical applications and future perspectives of GA, providing insights for its potential integration into endocrinology practice.